92 related articles for article (PubMed ID: 2999720)
1. Effect of N-(4-hydroxyphenyl)retinamide on murine mammary tumor cells in culture.
Bunk MJ; Telang NT; Higgins PJ; Traganos F; Sarkar NH
Nutr Cancer; 1985; 7(1-2):105-15. PubMed ID: 2999720
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of retinoic acid (RA) and N-(4-hydroxyphenyl) retinamide (4-HPR) on cell growth, induction of differentiation, and changes in p34cdc2, Bcl-2, and actin expression in the human promyelocytic HL-60 leukemic cells.
Dipietrantonio A; Hsieh TC; Wu JM
Biochem Biophys Res Commun; 1996 Jul; 224(3):837-42. PubMed ID: 8713132
[TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of skin carcinogenesis by phenylretinamides: retinoid receptor-independent tumor suppression.
Xu H; Cheepala S; McCauley E; Coombes K; Xiao L; Fischer SM; Clifford JL
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):969-79. PubMed ID: 16467112
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.
Ponzoni M; Bocca P; Chiesa V; Decensi A; Pistoia V; Raffaghello L; Rozzo C; Montaldo PG
Cancer Res; 1995 Feb; 55(4):853-61. PubMed ID: 7850799
[TBL] [Abstract][Full Text] [Related]
5. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid.
Delia D; Aiello A; Lombardi L; Pelicci PG; Grignani F; Grignani F; Formelli F; Menard S; Costa A; Veronesi U
Cancer Res; 1993 Dec; 53(24):6036-41. PubMed ID: 8261419
[TBL] [Abstract][Full Text] [Related]
6. Biotransformation and protein binding of N-(4-hydroxyphenyl)retinamide in murine mammary epithelial cells.
Bunk MJ; Kinahan JJ; Sarkar NH
Cancer Lett; 1985 Apr; 26(3):319-26. PubMed ID: 2986832
[TBL] [Abstract][Full Text] [Related]
7. Retinoid metabolism in the prostate: effects of administration of the synthetic retinoid N-(4-hydroxyphenyl)retinamide.
Lewis KC; Hochadel JF
Cancer Res; 1999 Dec; 59(23):5947-55. PubMed ID: 10606240
[TBL] [Abstract][Full Text] [Related]
8. Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolites.
Sabichi AL; Xu H; Fischer S; Zou C; Yang X; Steele VE; Kelloff GJ; Lotan R; Clifford JL
Clin Cancer Res; 2003 Oct; 9(12):4606-13. PubMed ID: 14555536
[TBL] [Abstract][Full Text] [Related]
9. Effects of pretreatment with the retinoid N-(4-hydroxyphenyl)-all-trans-retinamide and phenobarbital on the disposition and metabolism of N-(4-hydroxyphenyl)-all-trans-retinamide in mice.
Hultin TA; McCormick DL; May CM; Moon RC
Drug Metab Dispos; 1988; 16(6):783-8. PubMed ID: 2907453
[TBL] [Abstract][Full Text] [Related]
10. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F
Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676
[TBL] [Abstract][Full Text] [Related]
11. Distribution and metabolism of the retinoid, N-(4-methoxyphenyl)-all-trans-retinamide, the major metabolite of N-(4-hydroxyphenyl)-all-trans-retinamide, in female mice.
Hultin TA; Filla MS; McCormick DL
Drug Metab Dispos; 1990; 18(2):175-9. PubMed ID: 1971569
[TBL] [Abstract][Full Text] [Related]
12. Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl)retinamide and ovariectomy.
McCormick DL; Mehta RG; Thompson CA; Dinger N; Caldwell JA; Moon RC
Cancer Res; 1982 Feb; 42(2):508-12. PubMed ID: 6459843
[TBL] [Abstract][Full Text] [Related]
13. Hormonal induction of mammary tumor viruses and its implications for carcinogenesis.
McGrath CM; Jones RF
Cancer Res; 1978 Nov; 38(11 Pt 2):4112-25. PubMed ID: 212187
[TBL] [Abstract][Full Text] [Related]
14. N-(4-hydroxyphenyl)-all-trans-retinamide pharmacokinetics in female rats and mice.
Hultin TA; May CM; Moon RC
Drug Metab Dispos; 1986; 14(6):714-7. PubMed ID: 2877832
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of aberrant proliferation and induction of apoptosis in HER-2/neu oncogene transformed human mammary epithelial cells by N-(4-hydroxyphenyl)retinamide.
Jinno H; Steiner MG; Mehta RG; Osborne MP; Telang NT
Carcinogenesis; 1999 Feb; 20(2):229-36. PubMed ID: 10069458
[TBL] [Abstract][Full Text] [Related]
16. [Inhibitory effects on hepatocarcinoma and B16 melanoma cells by N-(4-hydrophenyl) retinamide].
Zhang L; Wu XZ
Shi Yan Sheng Wu Xue Bao; 2003 Dec; 36(6):421-7. PubMed ID: 14724932
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of mammary tumorigenesis in nulliparous C3H mice by chronic feeding of the synthetic retinoid, N-(4-hydroxyphenyl)-retinamide.
Welsch CW; DeHoog JV; Moon RC
Carcinogenesis; 1983 Sep; 4(9):1185-7. PubMed ID: 6224605
[TBL] [Abstract][Full Text] [Related]
18. Improved oral delivery of N-(4-hydroxyphenyl)retinamide with a novel LYM-X-SORB organized lipid complex.
Maurer BJ; Kalous O; Yesair DW; Wu X; Janeba J; Maldonado V; Khankaldyyan V; Frgala T; Sun BC; McKee RT; Burgess SW; Shaw WA; Reynolds CP
Clin Cancer Res; 2007 May; 13(10):3079-86. PubMed ID: 17505011
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis and restriction of G(1)/S cell cycle by fenretinide in Burkitt's lymphoma mutu I cell line accessed with bcl-6 down-regulation.
Hsieh T; Wu JM
Biochem Biophys Res Commun; 2000 Oct; 276(3):1295-301. PubMed ID: 11027625
[TBL] [Abstract][Full Text] [Related]
20. Induction of endogenous mammary tumor virus expression during hormonal induction of mammary adenoacanthomas and carcinomas of BALB/c female mice.
McGrath CM; Prass WA; Maloney TM; Jones RF
J Natl Cancer Inst; 1981 Oct; 67(4):841-52. PubMed ID: 6268884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
